Finally. Some bloody clarification. Superficially it reads well. I am more hopeful of a commercial collaboration from these results than FDA progression, but its great they are going to push with them on MACE basis. There is certainly some substance there....knee jerk reaction is the better results in NYHA class II showing the benefit of using their treatments early....
Ann: Rexlemestrocel Reduces Heart Attacks/Strokes/CV Death in CHF, page-36
-
- There are more pages in this discussion • 728 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
94.0¢ |
Change
-0.020(2.08%) |
Mkt cap ! $1.073B | |||
| Open | High | Low | Value | Volume |
| 95.5¢ | 97.0¢ | 93.5¢ | $1.424M | 1.507M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 29390 | 93.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 94.5¢ | 14089 | 2 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |